Page 135 - MSU Digital Book
P. 135

11. Uwaezuoke SN, Muoneke UV, Mbanefo NR. The supportive treatment of IgA

                  nephropathy and idiopathic nephrotic syndrome: how useful are omega-3
                  polyunsaturated fatty acids? Int J Nephrol Renovasc Dis. 2020;13:27-35.
              12. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, et al.

                  Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous
                  nephropathy. N Engl J Med 1984;310:946–50.

              13. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, et al. A randomized, controlled
                  trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused
                  by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18:1899–904.

              14. Ren S, Wang Y, Xian L, Toyama T, Jardine M, Li G, Perkovic V, Hong D.
                  Comparative effectiveness and tolerance of immunosuppressive treatments

                  for idiopathic membranous nephropathy: A network meta-analysis. PLoS One.
                  2017;12:e0184398.
              15. Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, et al. Idiopathic minimal change

                  nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
                  Nephrol Dial Transplant. 2003;18:1316-20.

              16. Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults
                  with nephrotic syndrome. Cochrane Database Syst Rev. 2008:CD001537.
              17. Korbet  SM.  Clinical  picture  and  outcome  of  primary  focal  segmental

                  glomerulosclerosis. Nephrol Dial Transplant. 1999;14 Suppl 3:68-73.
              18. Beer A, Mayer G, Kronbichler A. Treatment strategies of adult primary focal

                  segmental glomerulosclerosis: A systematic review focusing on the last two
                  decades. Biomed Res Int. 2016;2016:4192578.
              19. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, et al.

                  Clinical trial of focal segmental glomerulosclerosis in children and young adults.
                  Kidney Int. 2011;80:868-78.

              20. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immunosuppressive treatment of
                  membranoproliferative glomerulonephritis. Nephron. 1994;67:59-65.
              21. Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A. Treatment of

                  idiopathic membranoproliferative glomerulonephritis with mycophenolate
                  mofetil and steroids. Nephrol Dial Transplant 2004;19:3160–4.






              110
   130   131   132   133   134   135   136   137   138   139   140